Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2002, p. 8165-8174, Vol. 22, No. 23
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.23.8165-8174.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Yoshiaki Kamada,1,
Bradley R. Cairns,2 and David E. Levin1*
Department of Biochemistry & Molecular Biology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205,1 Howard Hughes Medical Institute, Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah 841122
Received 20 June 2002/ Returned for modification 5 August 2002/ Accepted 26 August 2002
| ABSTRACT |
|---|
|
|
|---|
mutant displayed temperature-sensitive growth and a G2/M cell cycle arrest at restrictive temperatures, a phenotype similar to that of strains with conditional mutations in essential RSC components. Second, we isolated RSC3, which encodes a component of the RSC complex, as a dosage suppressor of the htl1
growth arrest. Third, an htl1
mutant displayed additive growth defects with conditional rsc3 alleles. Fourth, overexpression of HTL1 suppressed the growth defect of a strain with a conditional mutation in another RSC component, RSC8. Finally, we demonstrate that Htl1 is a nuclear protein that can associate in vivo with a fraction of the RSC complex. We propose that an RSC-Htl1 complex acts coordinately with protein kinase C to regulate the G2/M transition. | INTRODUCTION |
|---|
|
|
|---|
The RSC complex exists in distinct forms, containing either Rsc1 or Rsc2, and with or without Rsc3 and Rsc30 (1, 5, 6). Moreover, the RSC subunit Sfh1 is phosphorylated during the G1 phase of the cell cycle (7), suggesting that chromatin remodeling by RSC is regulated at multiple levels. Additionally, rsc mutations affect expression of genes involved in cell wall biogenesis, ribosome biogenesis, the nitrogen discrimination pathway (NDP), carbon source utilization, and the TOR pathway. Recently, whole-genome occupancy studies have revealed the occupancy of RSC at hundreds of yeast genes, including those involved in NDP, carbon source utilization, the TOR pathway, histone genes, and tRNA genes (9, 34).
Genetic observations have revealed a functional link between RSC components and the cell wall integrity signaling pathway controlled by the Rho1 GTPase and Pkc1 (1, 7a, 14). This pathway monitors and regulates cell wall biogenesis during vegetative growth and in response to pheromone-induced morphogenesis (31). The master switch for cell wall signaling is Rho1, which is activated by several members of a family of cell surface sensors (12, 17, 22, 36, 39, 46).
Active Rho-GTP binds to and activates protein kinase C (21, 35), which is encoded by PKC1 (32). Loss of PKC1 function, or any of the components of the mitogen-activated protein (MAP) kinase cascade under its control (31), results in a cell lysis defect that is attributable to a deficiency in cell wall construction (29, 30, 37). The MAP kinase cascade is a linear pathway comprised of a MEKK (Bck1 [8, 27]), a pair of redundant MEKs (Mkk1/2 [15]), and a MAP kinase (Mpk1/Slt2 [26, 33]). One consequence of signaling through the MAP kinase cascade is the activation of the Rlm1 transcription factor (10, 47). Signaling through Rlm1 regulates the expression of at least 25 genes, most of which have been implicated in cell wall biogenesis (18).
Because the growth defect of a pkc1 null mutant is more severe than that of any of the pathway components that function downstream of this protein kinase, we have proposed that Pkc1 regulates a bifurcated pathway (30). To elucidate the nature of the second pathway branch and to identify novel targets of Pkc1, we conducted a screen for mutations that displayed additive growth defects with a pkc1ts mutation. Here we report the isolation of HTL1, a gene previously reported to be required for genomic stability and for growth at elevated temperatures (25). We demonstrate that HTL1 is important for cell cycle progression. Loss of function of HTL1 results in a G2/M arrest at restrictive temperatures that is similar to that observed in strains with conditional mutations of essential RSC subunits. Finally, we show that Htl1 interacts with the RSC complex both physically and functionally.
| MATERIALS AND METHODS |
|---|
|
|
|---|
mutants. Yeast cells were transformed by the lithium acetate method (16). Escherichia coli DH5
was used to propagate all plasmids. E. coli cells were cultured in Luria broth medium (1% Bacto Tryptone, 0.5% Bacto yeast extract, 1% NaCl) and transformed by standard methods.
|
Southern blotting for HTL1. The 666-bp HindIII fragment containing HTL1 was 32P labeled using the Multiprime random priming kit (Invitrogen Life Technologies). This labeled fragment was used to probe HindIII-digested genomic DNA (5 µg) from strains DL1248 or DL2822 separated on an agarose gel and transferred to a nitrocellulose membrane.
Genomic deletion of HTL1.
To disrupt the genomic copy of HTL1, 795 bp of sequence 5' to the HTL1 start codon and 1,030 bp of sequence 3' of the HTL1 stop codon were amplified in separate PCRs from genomic DNA of strain 1783. The 5' fragment was amplified with primers that placed a NotI site at the end adjacent to the HTL1 coding sequence and a BamHI site at the opposite end. The 3' fragment was amplified with primers that placed a KpnI site adjacent to the HTL1 coding sequence and a BamHI site at the opposite end. These fragments were ligated in a three-molecule reaction to the NotI and KpnI sites of the integrative plasmid pRS304 (42) to create a unique BamHI site between the fragments. The resulting plasmid, pRS304[htl1
::TRP1], was linearized with BamHI and used to transform the yeast strain to tryptophan prototrophy. Deletion of HTL1 in Trp+ transformants was confirmed by PCR. All primers were obtained from Invitrogen Life Technologies.
Isolation of RSC3 as a dosage suppressor of the htl1
growth defect.
A diploid yeast strain (DL2754 [htl1
/htl1
]) was used to avoid isolation of recessive suppressor mutations. This strain was cultured at 23°C in 50 ml of YEPD to an A600 of 0.8. Cells were transformed with a 2µm URA3-marked library (in pRS202; gift of F. Spencer) and plated on SD medium lacking uracil. Plates were incubated at 23°C for 1 day and shifted to 34°C for 2 to 3 days to select directly for suppressors. The smallest insert identified that was capable of suppressing the growth defect was a 4.3-kb fragment with one complete ORF (RSC3), 264 bp of the 3' end of CPR5, and 551 bp of the 3' end of GPI11. A 3.4-kb PvuII/MscI fragment containing RSC3 was subcloned into the SmaI site of the 2µm vector pRS426. This clone was capable of suppressing the temperature sensitivity of strain DL2754.
FACS analysis. Cultures of strains 1788 and DL2754, grown in YEPD plus 10% sorbitol at 23°C, were diluted to A600 of 0.2 with an equal volume of YEPD plus 10% sorbitol prewarmed to 54°C and cultured at 38°C for either 5 or 10 h (DL2754 loses viability upon longer maintenance at restrictive temperatures). The wild-type culture (strain 1788) was periodically diluted with prewarmed medium to maintain the cells in the logarithmic growth phase. Aliquots of 1 ml were drawn after 5 and 10 h at restrictive temperatures and prepared for fluorescence-activated cell sorting (FACS) analysis by a wash with phosphate-buffered saline (PBS) followed by overnight fixation in 70% ethanol at 4°C. Cells were washed with PBS, treated extensively with RNase A (1 mg/ml for 5 h at 37°C), washed again, and stained with 50 µg of propidium iodide per ml. Cells were sonicated briefly and diluted to a final concentration of 106 cells/ml for FACS analysis, which was performed with a Becton Dickinson FACSCalibur cytometer at the Johns Hopkins Flow Cytometry Core Facility. Another 1-ml aliquot of each culture was drawn at each time point for microscopy, washed with PBS, and resuspended in VectaShield with 4',6'-diamidino-2-phenylindole (DAPI) (1 µg/ml) for microscopic analysis.
Construction of HA- and FLAG-tagged HTL1.
To create HTL1-3xHA, HTL1 was PCR amplified from an HTL1 plasmid using primers that introduced a SacI site 794 bp 5' to the HTL1 translational start site and omitted the stop codon from the HTL1 coding sequence. This fragment was introduced into YEp352[3xHA] (39), creating an in-frame fusion at the 3' end of HTL1, with a glycyl codon between the HTL1 and hemagglutinin (HA)-coding sequences. This epitope-tagged form of Htl1 (Htl13xHA) was fully functional, as judged by its ability to complement the htl1
growth defect when expressed from a centromeric plasmid. This construction was used for indirect immunofluorescence microscopy with a Zeiss Axioskop microscope, as described previously (20). To create FlagHTL1, HTL1 was PCR amplified with a forward primer designed to contain a BamHI site immediately upstream of the Flag coding sequence (8 amino acids preceded by an ATG) followed by 24 bp of HTL1 sequence (omitting the endogenous start codon). The reverse primer was designed to place an EcoRI site downstream of the HTL1 stop codon. The PCR product was introduced into pRS426 containing the methionine-repressible MET25 promoter and the CYC1 transcriptional terminator (p426[MET25]) to yield pMET-Flag-HTL1. This plasmid complemented the htl1
growth defect even when expression of FlagHtl1 was repressed with methionine.
Association of Flag-tagged Htl1 with RSC complex. Yeast strain YBC928 was transformed to uracil prototrophy with either pMET-Flag-HTL1 or empty vector. Transformants were cultured at 28°C in YEPD; extracts were prepared as described previously (6). For immunoprecipitation of FlagHtl1, anti-Flag M2 affinity gel or control beads (Sigma) were incubated for 2 h with 300 µg of protein extract in immunoprecipitation (IP) buffer A (50 mM Tris-Cl [pH 7.5], 10% glycerol, 100 mM NaCl, 2 mM EDTA, ß-mercaptoethanol). Precipitates were recovered and washed in IP buffer A containing 250 mM NaCl and 0.05% Tween 20 and eluted with 0.2 mg of Flag peptide (Sigma) per ml in IP buffer A. Proteins from crude extracts, Flag-Htl1-depleted supernatant fractions, and eluates were separated on a gradient sodium dodecyl sulfate (SDS)-10 to 20% (acrylamide) polyacrylamide gel (Bio-Rad), and transferred to polyvinylidene difluoride membranes for immunoblot detection of FlagHtl1 with anti-Flag antibodies (Sigma) and of Sth1 with anti-Sth1 antibodies (1). The extracts described above were also used for immunoprecipitation of Sth1. Anti-Sth1 antibodies were conjugated to protein A-Sepharose beads (Sigma) at a concentration of 0.5 mg/ml in IP buffer A; the beads and antibodies h were then incubated for 2 h with 300 µg of protein extract and treated as described above, except that immunoprecipitates were eluted with SDS sample buffer.
| RESULTS |
|---|
|
|
|---|
|
To examine the behavior of a null mutation in HTL1 alone, we constructed a genomic deletion of HTL1 in wild-type strain 1788. Heterozygous htl1
::TRP1 diploids were induced to sporulate, and haploid segregants were dissected. Tryptophan prototrophy cosegregated with temperature sensitivity for growth at or above 34°C, consistent with the previous report by Lanzuolo et al. (25). As anticipated, the htl1
mutants were capable of growth on glycerol-containing medium (Fig. 1A).
We next tested for additive growth defects caused by combining null mutations in HTL1 and either PKC1 or BCK1. Doubly heterozygous diploids were generated by crossing an htl1
::TRP1 strain (DL2751) with a pkc1
::LEU2 strain (DL376). A total of 56 tetrads were dissected and allowed to germinate at 23°C on medium containing 10% sorbitol for osmotic support. Although both single mutants and wild-type segregants were recovered at the expected frequencies, no viable Leu+ Trp+ spores were recovered, indicating that the combined loss of PKC1 and HTL1 functions is lethal. HTL1 was also deleted in a heterozygous bck1
/BCK1 diploid (DL2315). The resultant transformants were induced to sporulate, and haploid segregants germinated at 23°C. Although the bck1
htl1
segregants were able to grow on YEPD at 23°C, they failed to grow at or above 30°C (Fig. 2). This restrictive temperature was 4°C lower than that of the htl1
mutant, which grew poorly at 30°C. This result indicates only mild additivity of the htl1
and bck1
growth defects. Additionally, the double mutant displayed a cell lysis defect, as judged by the presence of nonrefractile ghosts (not shown) that was similar to that of bck1
mutants at restrictive temperatures. However, we were not able to detect a cell wall deficiency in htl1
mutants using tests for hypersensitivity to the cell wall lytic enzyme zymolyase or the cell wall antagonist caffeine (data not shown).
|
cells at restrictive temperatures revealed that this mutant arrested growth with a nearly uniform morphology. For all mating types, 80 to 90% of cells arrested with single, medium- to large-sized buds, single nuclei, and no evidence of cell lysis (Fig. 3A). To determine whether htl1
cells arrest in the cell division cycle before or after DNA replication, we assessed the DNA content of this mutant cultivated at either low or high temperatures. Log-phase cultures of diploid wild-type (1788) or htl1
cells (DL2754) were shifted from 23 to 38°C for 5 or 10 h to measure DNA content by FACS analysis. The htl1
mutant displayed an enriched population of 4N cells at low temperatures compared to the wild-type population, suggesting a delay at the G2/M boundary (Fig. 3B). Moreover, at restrictive temperatures, 90% of the htl1
cells accumulated 4N nuclei, indicating a postreplicative arrest at G2/M. Similar results were obtained with haploid htl1
cells (data not shown).
|
.
To gain an understanding of the htl1
growth defect, we isolated multicopy suppressors of an htl1
/htl1
mutant (DL2754). Suppressors were selected directly at 34°C on SD plates lacking uracil after transformation with a 2µm URA3-marked genomic library. Of
80,000 transformants selected, 8 colonies arose at the restrictive temperature. Among the plasmids rescued from these colonies, four contained wild-type HTL1, and four possessed overlapping DNA fragments from the right arm of chromosome IV. The only complete gene common to all four plasmids was RSC3 (named RSC for remodels the structure of chromatin) (data not shown). Deletion analysis revealed that RSC3 alone, when expressed from a 2µm plasmid, was sufficient to allow an htl1
/htl1
mutant to grow at 34°C (Fig. 4A). The RSC3 gene encodes an essential component of the RSC complex, which alters gene expression by remodeling of chromatin (1). Rsc3 is highly similar to well-characterized fungal DNA-binding proteins (such as Gal4), as it contains an essential binuclear zinc cluster followed by a leucine zipper. Some genes involved in the maintenance of cell wall integrity are among those regulated by RSC (1). Interestingly, conditional mutations in RSC3 and other essential genes encoding RSC members arrest growth at the G2/M boundary (1, 7, 9, 45), with a terminal morphology that is very similar to that observed for htl1
cells. However, overexpression of HTL1 failed to suppress the growth defects of any of the three conditional rsc3 alleles.
|
/htl1
mutants (data not shown), consistent with the different roles these components serve in RSC function.
Deletion of HTL1 results in additive growth defects with rsc3 mutations.
Because RSC3 is an essential gene, we tested a set of conditional rsc3 mutations for additive growth defects with htl1
. The htl1
mutation was introduced into strains bearing one of three temperature-sensitive alleles of RSC3 (rsc3-1, -2, and -3 [1]) and a centromeric URA3-based plasmid with HTL1. These strains were tested for the ability to survive loss of the plasmid-borne HTL1 at 23°C by plating on 5-FOA-containing medium to evict the plasmid. Figure 4B shows that both the rsc3-2 htl1
and rsc3-3 htl1
mutants were unable to grow on 5-FOA-containing medium, indicating that loss of HTL1 is lethal in these mutants. Together with the observation that RSC3 is a dosage suppressor of htl1
, these results suggest that HTL1 and RSC3 function within the same pathway.
HTL1 is a dosage suppressor of an rsc8tsmutant. The RSC8 gene encodes a component of the RSC complex, and homologs of Rsc8 are present in all SWI/SNF family remodeling complexes (5, 44). Though the precise role of Rsc8 is not known, studies on its human homolog, BAF155/170, suggest that this subunit interacts with the ATPase subunit Brg1 and also with gene-specific transcriptional activators such as EKLF (2). Treich et al. (44) reported previously that a DNA fragment bearing the MAK31 and HTL1 loci could suppress the growth defect of an rsc8ts mutant (swh3-ts16) when maintained at high copy number. To test whether this suppression was the result of HTL1 overexpression, a 2µm plasmid bearing only HTL1 was introduced to the swh3-ts16 mutant (MCY3890 [44]). This clone was able to suppress the growth defect of swh3-ts16 (Fig. 4C), demonstrating that HTL1, not MAK31, is the multicopy suppressor of swh3-ts16 obtained by Treich et al. (44), and further supporting the notion that Htl1 functions in the same pathway as the RSC complex.
Htl13xHA resides in the nucleus. The RSC complex resides in the nucleus (9, 45). As an initial step toward establishing a physical connection between Htl1 and RSC, we determined the intracellular location of Htl1. Htl1 was fused at its C terminus to a triple-HA epitope (3xHA). Htl13xHA expressed from a 2µm plasmid colocalized with DAPI, indicating nuclear localization (Fig. 5). Similar results were obtained when Htl13xHA was expressed from a centromeric plasmid but with a less intense signal (data not shown).
|
|
| DISCUSSION |
|---|
|
|
|---|
Htl1 can associate with the RSC complex.
We present four lines of evidence supporting the conclusion that Htl1 interacts physically and functionally with the RSC complex. First, at restrictive temperatures, htl1 null mutants exhibit a uniform cell cycle arrest in G2/M that is similar to that of strains with conditional mutations in some essential components of the RSC complex (e.g., alleles of STH1, SFH1, RSC3, and RSC9 [1, 7, 9, 45]). For reasons that are not clear, the cell cycle-specific arrest of an htl1 null mutant was not observed in a previous study (25). Strain background differences may explain this disparity, as may the possible acquisition of suppressor mutations. Second, conditional rsc3 haploid strains accumulate cells with 4N DNA content (1), as was shown for htl1
haploids (25). Third, multicopy suppression experiments revealed a genetic interaction between HTL1 and RSC components. Specifically, overexpression of RSC3, an essential DNA-binding component of the RSC complex, suppressed the growth defect of an htl1 null mutant. Additionally, overexpression of HTL1 suppressed the growth defect of a conditional rsc8 mutant. The observation that an increased dose of HTL1 could not suppress the growth defect of any of three conditional rsc3 mutations suggests that its overexpression can compensate for some RSC defects, but not others. Fourth, Htl1 is a nuclear protein that when overexpressed was found to associate in vivo with known RSC complex components Rsc3 and Sth1.
A recent quantitative study of proteins associated with the general transcription factor TFIID (41), which is a multisubunit complex comprised of the TATA-binding protein (TBP) and 14 TBP-associated factors (TAFs), revealed that all known RSC components were among the constellation of proteins that displayed preferential association with TBP (compared with TAFs). Htl1 was among the other, non-RSC proteins identified in this population. Our results, which indicate that Htl1 can associate with RSC, provide an explanation for the reported association of Htl1 with TBP.
Why was Htl1 not identified in previous characterizations of RSC components? The most likely explanation is that Htl1 appears to exist in substoichiometric amounts within the RSC complex. We found that cell extracts that were immunodepleted of overexpressed FlagHtl1 still possessed some of the Sth1 subunit. Moreover, it was possible to detect FlagHtl1 associated with immunoprecipitates of Sth1 only when the former was greatly overproduced. This may be significant in light of the observation that RSC exists in forms that either possess or are devoid of Rsc3/30 (5). The genetic interaction we observed between HTL1 and RSC3 may reflect a specific association of Htl1 with the form of RSC that contains Rsc3/30. The Rsc3/30 proteins exist as a heterodimeric complex that can form outside of the RSC complex (1). Interestingly, although these closely related components serve overlapping roles, they may act antagonistically for certain functions. Our finding that the htl1 null growth defect was suppressed by overexpression of RSC3, but not RSC30, underscores the functional differences between these components.
Interactions between the RSC complex and Pkc1. Recent studies have raised the possibility that RSC function is regulated by Pkc1. First, a genetic screen for multicopy suppressors of the growth defect of a temperature-sensitive mutation in STH1/NPS1, which encodes the DNA-dependent ATPase of the RSC complex, yielded upstream components of the cell wall integrity pathway, including PKC1 (14). Overexpression or mutational activation of elements of the MAP kinase cascade controlled by Pkc1 failed to suppress sth1, prompting these investigators to suggest that the observed effect of Pkc1 is not mediated by the MAP kinase pathway. Additive growth defects between conditional alleles of STH1 (nps1-105) and PKC1 (stt1-1) also support a functional connection to RSC (14). A recent study by Chai et al. (7a) confirmed these findings using another allele of STH1 (sth1-3) and also demonstrated additive growth defects between sth1-3 and a null mutation in the cell surface sensor for Pkc1 activation encoded by WSC1. Second, mutation of either RSC3 or RSC30 alters the expression of several genes implicated in cell wall biogenesis, and the sensitivity to caffeine and formamide displayed by conditional RSC3 mutants is suppressed by overexpression of PKC1 (1). Moreover, rsc3 mutations are lethal in combination with a pkc1 null allele (even in the presence of osmotic support), but not a bck1 null allele. Collectively, these observations strongly suggest a functional link between Pkc1 and RSC.
Loss of Pkc1 function results in cell lysis resulting from a deficit in cell wall construction (29, 30). However, loss of function in the MAP kinase cascade regulated by Pkc1 results in cell lysis only at elevated temperatures (30), indicating that Pkc1 regulates at least one other pathway that contributes to cell wall integrity. We found that loss of HTL1 function was lethal in the presence of pkc1 mutations but resulted in only mild defect additivity with a bck1 null allele, similar to the behavior of other rsc mutants. Although the observed defect additivity suggests that htl1 mutants may suffer a deficiency in cell wall biogenesis, we observed no evidence of cell lysis at restrictive temperatures and were unable to detect a cell wall defect through tests for hypersensitivity to cell wall stresses.
An interesting alternative explanation for the observed defect additivity between pkc1 and htl1 invokes a role for Pkc1 in passage through G2/M. Depletion of Pkc1 results in cell lysis at the bud tip during a distinct period in the cell cycle, previously interpreted to reflect the point at which the cell is most sensitive to cell wall stress (30). Such cells die uniformly with single, postreplication nuclei and small buds (32). This is also the case for conditional alleles of pkc1 (29). Hosotani et al. (14) recently extended these observations, finding that a conditional pkc1 mutant (stt1-1) undergoes a G2/M delay at permissive temperatures. These investigators suggested that Pkc1 might have a cell cycle function that is independent of cell wall metabolism. Because we isolated an htl1 mutant in a synthetic lethal screen with stt1-1, our finding that an htl1 null mutant also displays a G2/M delay at permissive temperatures suggests that a double pkc1 htl1 mutant may succumb to a G2/M block. A cell cycle block could explain our inability to rescue this double mutant by osmotic support.
Models for RSC/Htl1 function and Pkc1 cooperativity in cell wall biogenesis and cell cycle progression.
The striking defect additivity observed between pkc1
and either rsc3 alleles (1) or htl1
suggests that cell viability requires either intact Pkc1 function or intact RSC function. However, this relationship (and other data) does not establish whether these factors function together in a single pathway or coordinately in parallel pathways (Fig. 7). In considering a single pathway, Pkc1 could phosphorylate RSC components and alter RSC function at loci important for cell wall biogenesis and G2/M progression. Clearly, Pkc1 regulation of RSC would have to be limited to a subset of RSC functions, because null mutations in most RSC components are lethal even in the presence of osmotic support (pkc1
mutants are viable under these conditions). Moreover, RSC occupies hundreds of genes not related to Pkc1 function. However, to date, we have been unable to detect phosphorylation of purified RSC by Pkc1 in vitro (unpublished observations), though we have not ruled out the possibility that RSC is a Pkc1 target in vivo. A second model equally consistent with our data are that Pkc1 and RSC act coordinately in parallel pathways to regulate cell wall biogenesis and passage through G2/M. In this case, RSC components are not direct targets of Pkc1. Instead, the functions of both of these factors are required for proper expression of genes involved in cell wall biogenesis and passage through the G2/M transition. In either case, our data strongly suggest that Htl1 assists RSC primarily for proper passage through G2/M phase (Fig. 7), as htl1 null mutants phenotypically copy the G2/M cell cycle block observed in certain rsc mutants but lack the cell wall phenotypes associated with rsc3 mutations.
|
| ACKNOWLEDGMENTS |
|---|
This work was supported in part by NIH grants GM48533 to D.E.L. and GM60415 to B.R.C. Training grant 5T32CA09110 supported M.J.R. and A.K.S. Training grant T32GM07464 supported M.L.A.-H. B.R.C. is an Assistant Investigator with the Howard Hughes Medical Institute.
| FOOTNOTES |
|---|
Present address: Institut de Genetique et Microbiologie, Université Paris-Sud, 91405 Orsay Cedex, France. ![]()
Present address: Department of Cell Biology, National Institute for Basic Biology, Okazaki 444-8585, Japan. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Armstrong, J. A., J. J. Bieker, and B. M. Emerson. 1998. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell 95:93-104.[CrossRef][Medline]
3. Boeke, J. D., F. LaCroute, and G. R. Fink. 1984. A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol. Gen. Genet. 197:345-346.[CrossRef][Medline]
4. Cairns, B. R. 1998. Chromatin remodeling machines: similar motors, ulterior motives. Trends Biochem. Sci. 23:20-25.[CrossRef][Medline]
5. Cairns, B. R., Y. Lorch, Y. Li, M. Zhang, L. Lacomis, H. Erdjument-Bromage, P. Tempst, J. Du, B. Laurent, and R. D. Kornberg. 1996. RSC, an essential, abundant chromatin-remodeling complex. Cell 87:1249-1260.[CrossRef][Medline]
6. Cairns, B. R., A. Schlichter, H. Erdjument-Bromage, P. Tempst, R. D. Kornberg, and F. Winston. 1999. Two functionally distinct forms of the RSC nucleosome-remodeling complex, containing essential AT hook, BAH, and bromodomains. Mol. Cell 4:715-723.[CrossRef][Medline]
7. Cao, Y., B. R. Cairns, R. D. Kornberg, and B. C. Laurent. 1997. Sfh1p, a component of a novel chromatin-remodeling complex, is required for cell cycle progression. Mol. Cell. Biol. 17:3323-3334.[Abstract]
7. Chai, B., J. Hsu, J. Du, and B. C. Laurent. 2002. Yeast RSC function is required for organization of the cellular cytoskeleton via an alternative PKC1 pathway. Genetics 161:575-584.
8. Costigan, C., S. Gehrung, and M. Snyder. 1992. A synthetic lethal screen identifies SLK1, a novel protein kinase homolog implicated in yeast cell morphogenesis and cell growth. Mol. Cell. Biol. 12:1162-1178.
9. Damelin, M., I. Simon, T. I. Moy, B. Wilson, S. Komili, P. Tempst, F. P. Roth, R. A. Young, B. R. Cairns, and P. A. Silver. 2002. The genome-wide localization of Rsc9, a component of the RSC chromatin-remodeling complex, changes in response to stress. Mol. Cell 9:563-573.[CrossRef][Medline]
10. Dodou, E., and R. Treisman. 1997. The Saccharomyces cerevisiae MADS-box transcription factor Rlm1 is a target for the Mpk1 mitogen-activated protein kinase pathway. Mol. Cell. Biol. 17:1848-1859.[Abstract]
11. Du, J., I. Nasir, B. K. Benton, M. P. Kladde, and B. C. Laurent. 1998. Sth1p, a Saccharomyces cerevisiae Snf2p/Swi2p homolog, is an essential ATPase in RSC and differs from Snf/Swi in its interactions with histones and chromatin-associated proteins. Genetics 150:987-1005.
12. Gray, J. V., J. P. Ogas, Y. Kamada, M. Stone, D. E. Levin, and I. Herskowitz. 1997. A role for the Pkc1 MAP kinase pathway of Saccharomyces cerevisiae in bud emergence and identification of a putative upstream regulator. EMBO J. 16:4924-4937.[CrossRef][Medline]
13. Hill, J. E., A. M. Muers, T. J. Koerner, and A. Tzagoloff. 1986. Yeast/E. coli shuttle vectors with multiple unique restriction sites. Yeast 2:163-167.[CrossRef][Medline]
14. Hosotani, T., H. Koyama, M. Uchino, T. Miyakawa, and E. Tsuchiya. 2001. PKC1, a protein kinase C homologue of Saccharomyces cerevisiae, participates in microtubule function through the yeast EB1 homologue, BIM1. Genes Cells 6:775-788.[Abstract]
15. Irie, K., M. Takase, K. S. Lee, D. E. Levin, H. Araki, K. Matsumoto, and Y. Oshima. 1993. MKK1 and MKK2, which encode Saccharomyces cerevisiae mitogen-activated protein kinase-kinase homologs, function in the pathway mediated by protein kinase C. Mol. Cell. Biol. 13:3076-3083.
16. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
17. Jacoby, J. J., S. M. Nilius, and J. J. Heinisch. 1998. A screen for upstream components of the yeast protein kinase C signal transduction pathway identifies the product of the SLG1 gene. Mol. Gen. Genet. 258:148-155.[CrossRef][Medline]
18. Jung, U. S., and D. E. Levin. 1999. Genome-wide analysis of gene expression regulated by the yeast cell wall integrity signaling pathway. Mol. Microbiol. 34:1049-1057.[CrossRef][Medline]
19. Kadonaga, J. T. 1998. Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92:307-313.[CrossRef][Medline]
20. Kamada, Y., U. S. Jung, J. Piotrowski, and D. E. Levin. 1995. The protein kinase C-activated MAP kinase pathway of Saccharomyces cerevisiae mediates a novel aspect of the heat shock response. Genes Dev. 9:1559-1571.
21. Kamada, Y., H. Qadota, C. P. Python, Y. Anraku, Y. Ohya, and D. E. Levin. 1996. Activation of yeast protein kinase C by Rho1 GTPase. J. Biol. Chem. 271:9193-9195.
22. Ketela, T., R. Green, and H. Bussey. 1999. Saccharomyces cerevisiae Mid2p is a potential cell wall stress sensor and upstream activator of the PKC1-MPK1 cell integrity pathway. J. Bacteriol. 181:3330-3340.
23. Kingston, R. E., and G. J. Narlikar. 1999. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 13:2339-2352.
24. Kornberg, R. D., and Y. Lorch. 1999. Chromatin-modifying and -remodeling complexes. Curr. Opin. Genet. Dev. 9:148-151.[CrossRef][Medline]
25. Lanzuolo, C., S. Ederle, A. Pollice, F. Russo, A. Storlazzi, and J. F. Pulitzer. 2001. The HTL1 gene (YCR020W-b) of Saccharomyces cerevisiae is necessary for growth at 37°C, and for the conservation of chromosome stability and fertility. Yeast 18:1317-1330.[CrossRef][Medline]
26. Lee, K. S., K. Irie, Y. Gotoh, Y. Watanabe, H. Araki, E. Nishida, K. Matsumoto, and D. E. Levin. 1993. A yeast mitogen-activated protein kinase homolog (Mpk1) mediates signaling by protein kinase C. Mol. Cell. Biol. 13:3067-3075.
27. Lee, K. S., and D. E. Levin. 1992. Dominant mutations in a gene encoding a putative protein kinase (BCK1) bypass the requirement for a Saccharomyces cerevisiae protein kinase C homolog. Mol. Cell. Biol. 12:172-182.
28. Leibowitz, M. J., and R. B. Wickner. 1978. Pet18: a chromosomal gene required for cell growth and for the maintenance of mitochondrial DNA and the killer plasmid of yeast. Mol. Gen. Genet. 165:115-121.[CrossRef][Medline]
29. Levin, D. E., and E. Bartlett-Heubusch. 1992. Mutants in the S. cerevisiae PKC1 gene display a cell cycle-specific osmotic stability defect. J. Cell Biol. 116:1221-1229.
30. Levin, D. E., B. Bowers, C. Chen, Y. Kamada, and M. Watanabe. 1994. Dissecting the protein kinase C/MAP kinase signaling pathway of Saccharomyces cerevisiae. Cell. Mol. Biol. Res. 40:229-239.[Medline]
31. Levin, D. E., and B. Errede. 1995. The proliferation of MAP kinase signaling pathways in yeast. Curr. Opin. Cell Biol. 7:197-202.[CrossRef][Medline]
32. Levin, D. E., F. O. Fields, R. Kunisawa, J. M. Bishop, and J. Thorner. 1990. A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle. Cell 62:213-224.[CrossRef][Medline]
33. Martin, H., J. Arroyo, M. Sanchez, M. Molina, and C. Nombela. 1993. Activity of the yeast MAP kinase homolog Slt2 is critically required for cell integrity at 37°C. Mol. Gen. Genet. 241:177-184.[CrossRef][Medline]
34. Ng, H. H., F. Robert, R. A. Young, and K. Struhl. 2002. Genome-wide location and regulated recruitment of the RSC nucleosome-remodeling complex. Genes Dev. 16:806-819.
35. Nonaka, H., K. Tanaka, H. Hirano, T. Fujiwara, H. Kohno, M. Umikawa, A. Mino, and Y. Takai. 1995. A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae. EMBO J. 14:5931-5938.[Medline]
36. Ozaki, K., K. Tanaka, H. Imamura, T. Hihara, T. Kamayema, H. Nonaka, H. Hirano, Y. Matsuura, and Y. Takai. 1996. Rom1p and Rom2p are small GDP/GTP exchange proteins (GEPs) for the Rho1p small GTP-binding protein in Saccharomyces cerevisiae. EMBO J. 15:2196-2207.[Medline]
37. Paravicini, G., M. Cooper, L. Friedli, D. J. Smith, J.-L. Carpentier, L. S. Klig, and M. A. Payton. 1992. The osmotic integrity of the yeast cell requires a functional PKC1 gene product. Mol. Cell. Biol. 12:4896-4905.
38. Peterson, C. L., and J. L. Workman. 2000. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. 10:187-192.[CrossRef][Medline]
39. Rajavel, M., B. Philip, B. M. Buehrer, B. Errede, and D. E. Levin. 1999. Mid2 is a putative sensor for cell integrity signaling in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:3969-3976.
40. Rose, M. D., F. Winston, and P. Hieter. 1990. Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
41. Sanders, S. L., J. Jennings, A. Canutescu, A. J. Link, and P. A. Weil. 2002. Proteomics of the eukaryotic transcription machinery: identification of proteins associated with components of yeast TFIID by multidimensional mass spectrometry. Mol. Cell. Biol. 22:4723-4738.
42. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
43. Toh-e, A., and Y. Sahashi. 1985. The PET18 locus of Saccharomyces cerevisiae: a complex locus containing multiple genes. Yeast 1:159-171.[CrossRef][Medline]
44. Treich, I., L. Ho, and M. Carlson. 1998. Direct interaction between Rsc6 and Rsc8/Swh3, two proteins that are conserved in SWI/SNF-related complexes. Nucleic Acids Res. 26:3739-3745.
45. Tsuchiya, E., M. Uno, A. Kiguchi, K. Masuoka, Y. Kanemori, S. Okabe, and T. Mikayawa. 1992. The Saccharomyces cerevisiae NPS1 gene, a novel CDC gene which encodes a 160 kDa nuclear protein involved in G2 phase control. EMBO J. 11:4017-4026.[Medline]
46. Verna, J., A. Lodder, K. Lee, A. Vagts, and R. Ballester. 1997. A family of genes required for the maintenance of cell wall integrity and for the stress response in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. 94:13804-13809.
47. Watanabe, Y., G. Takaesu, M. Hagiwara, K. Irie, and K. Matsumoto. 1997. Characterization of a serum response factor-like protein in Saccharomyces cerevisiae, Rlm1, which has transcriptional activity regulated by the Mpk1 (Slt2) mitogen-activated protein kinase pathway. Mol. Cell. Biol. 17:2615-2623.[Abstract]
48. Wu, C., T. Tsukiyama, D. Gdula, P. Georgel, M. Martinez-Balbas, G. Mizuguchi, V. Ossipow, R. Sanaltzopoulos, and H. M. Wang. 1998. ATP-remodeling of chromatin. Cold Spring Harbor Symp. Quant. Biol. 63:525-534.
49. Yoshida, S., E. Ikeda, I. Uno, and H. Mitsuzawa. 1992. Characterization of a staurosporine- and temperature-sensitive mutant, stt1, of Saccharomyces cerevisiae: STT1 is allelic to PKC1. Mol. Gen. Genet. 231:337-344.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||